DIAGNOSIS OF MYCOPLASMA-PNEUMONIAE INFECTION BY SPECIFIC IGM ANTIBODIES USING A NEW CAPTURE-ENZYME-IMMUNOASSAY

被引：12

作者：

SAMRA, Z

GADBA, R

机构：

[1] Mycoplasma National Reference Center - Department of Microbiology - Beilinson Medical Center Petah, of Medicine, Tel Aviv University, Petah Tiqva

来源：

EUROPEAN JOURNAL OF EPIDEMIOLOGY | 1993年 / 9卷 / 01期

关键词：

MYCOPLASMA-PNEUMONIAE; IGM ANTIBODIES; DIAGNOSIS;

D O I：

10.1007/BF00463097

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

A total of 1226 sera from 1055 patients with respiratory tract infections were tested. IgM antibodies were detected by an antibody-capture enzyme-immunoassay (Mp TEST, Diatech Diagnostica Ltd, Israel). Acute infection with IgM antibodies to Mycoplasma pneumoniae was detected in 211 patients. Presence of IgM was closely associated to some or all pneumonia-related symptoms. Eighty-one of IgM-positive patients treated with tetracycline or erythromycin responded positively. Of the 211 patients, 63 (30%) had low levels and 23 (11%) had moderate levels of IgM antibodies already in the first serum sample. In these 86 patients (41%) the complement fixation (CF) test was negative or very low positive. Thus in these cases, the CF test would have missed the early diagnosis in the first serum samples.

引用

页码：97 / 99

页数：3

共 10 条

[1]

Barker C.E., Siblis M., Wreghitt T.G., Evaluation of Serodia Myco 11 particle agglutination test for detection of Mycoplasma pneumoniae antibody: comparison with u-capture ELISA and indirect immunofluorescence, J. Clin. Pathol., 43, pp. 163-165, (1991)

[2]

Cassel G.H., Cole B.C., Mycoplasma agents of human disease, New England Journal of Medicine, 304, pp. 80-89, (1981)

[3]

Echevarria J.M., Leon P., Balfagon P., Lopez J.A., Fernandez M.V., Diagnosis of Mycoplasma pneumoniae infection by microparticle agglutination and antibody capture enzyme-immunoassay, Eur. J. Clin. Microbiol. Inf. Dis., 9, pp. 217-220, (1990)

[4]

Finnegan O.C., Fowles S.J., White R.J., Radiographic appearance of Mycoplasma pneumoniae, Thorax, 36, pp. 469-472, (1981)

[5]

Hirschberg L., Krook A., Pettersson C.A., Vikersfors T., Enzyme-linked immunosorbent assay for detection of Mycoplasma pneumoniae specific immunoglobulin M., Eur. J. Clin. Microbiol. Inf. Dis., 7, pp. 420-423, (1988)

[6]

Levine D.P., Lerner A.M., The clinical spectrum of Mycoplasma pneumoniae infections, Med. Clin. North Am., 72, pp. 961-978, (1978)

[7]

Moule J.H., Caul E.0., The specific IgM response to Mycoplasma pneumoniae infection: interpretation and application to early diagnosis, Epid. Inf., 99, pp. 685-692, (1987)

[8]

Ponka A., Ponka T., Sarna S., Penttinen K., Questionable specificity of lipid antigen in Mycoplasma pneumoniae CF test in patients with extrapulmonary manifestation, J. Infection, 3, pp. 332-338, (1981)

[9]

Tilton R.C., Dias F., Kidd H., Ryan R.W., DNA probe versus culture for detection of Mycoplasma pneumoniae in clinical specimens, 10, pp. 109-112, (1988)

[10]

Vikerfors T., Bordin G., Grandien M., Hirschberg L., Brook A., Petterson C., Detection of specific IgM antibodies for the diagnosis of Mycoplasma pneumoniae infection: A clinical evaluation, Scand. J. Inf. Dis., 20, pp. 601-610, (1988)

← 1 →